Correction to: Mesoporous Bowl-Shaped Polydopamine Co-Loaded Temozolomide and Indocyanine Green for Synergistically Inhibiting Glioblastoma
This correction addresses an image misuse in the original publication (Sci China Mater, 2025, 68(6): 2095, DOI: 10.1007/s40843-025-3311-6). Specifically, a fluorescent image in Fig. 4d, depicting live/dead cells after treatment with MPDA@TMZ without laser irradiation, was erroneously presented. The corrected Fig. 4 is provided, and the authors confirm that the results and conclusions of the original paper remain unaffected. The correction ensures the integrity of the reported data, particularly the cell viability and apoptosis assays. The study focuses on mesoporous bowl-shaped polydopamine (MPDA) nanoparticles co-loaded with temozolomide (TMZ) and indocyanine green (ICG) for synergistic glioblastoma therapy. The corrected figure includes CLSM images of G422 cells after incubation with various formulations (ICG, sPDA@ICG, mPDA@ICG, MPDA@ICG), cell viability curves, quantitative fluorescence intensity, live/dead staining, and apoptosis quantification. Statistical significance is denoted as ****p < 0.01. The correction maintains the scientific validity of the findings, which demonstrate the potential of MPDA-based nanoplatforms for combined chemo-photothermal therapy.